Immune and glial cell factors as pain mediators and modulators
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Experimental Neurology
- Vol. 192 (2), 444-462
- https://doi.org/10.1016/j.expneurol.2004.11.001
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust
This publication has 170 references indexed in Scilit:
- MAPK activation in nociceptive neurons and pain hypersensitivityLife Sciences, 2004
- Activation of P2X7 purinoceptor-stimulated TGF-β1 mRNA expression involves PKC/MAPK signalling pathway in a rat brain-derived type-2 astrocyte cell line, RBA-2Cellular Signalling, 2003
- GLIA: A novel drug discovery target for clinical painNature Reviews Drug Discovery, 2003
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- TNF-α receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neuronesNeuropharmacology, 2001
- Hyperalgesia due to nerve damage: role of nerve growth factorPain, 1999
- Tumor Necrosis Factor-α Mediates the Release of Bioactive Transforming Growth Factor-β in Murine Microglial Cell CulturesClinical Immunology and Immunopathology, 1995
- Calcitonin gene‐related peptide and ATP induce immediate early gene expression in cultured rat microglial cellsGlia, 1995
- The effect of systemically administered recombinant human nerve growth factor in healthy human subjectsAnnals of Neurology, 1994
- NGF receptor-mediated reduction in axonal NGF uptake and retrograde transport following sciatic nerve injury and during regenerationNeuron, 1991